The prevalence of asthma-COPD overlap (ACO) among COPD patients and the role of prostaglandin D2 (PGD2) in differential diagnosis “about”

Basit Öğe Kaydı
dc.contributor.authorAtlı, Siahmet
dc.date.accessioned2026-09-08T07:08:41Z
dc.date.issued2026
dc.departmentFırat Üniveristesi
dc.description.abstract[No abstract available]
dc.identifier.doi10.31362/patd.1948929
dc.identifier.endpage666
dc.identifier.issn1309-9833
dc.identifier.issue3
dc.identifier.scopus2-s2.0-105046385751
dc.identifier.scopusqualityQ4
dc.identifier.startpage665
dc.identifier.urihttps://doi.org/10.31362/patd.1948929
dc.identifier.urihttps://hdl.handle.net/11508/64986
dc.identifier.volume19
dc.indekslendigikaynakScopus
dc.institutionauthorAtlı, Siahmet
dc.language.isoen
dc.publisherPamukkale University
dc.relation.ispartofPamukkale Medical Journal
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_Scopus_20250903
dc.subjectBiological Marker
dc.subjectBronchodilating Agent
dc.subjectProstaglandin D2 Derivative
dc.subjectAsthma
dc.subjectChronic Obstructive Lung Disease
dc.subjectClassification
dc.subjectDifferential Diagnosis
dc.subjectForced Expiratory Volume
dc.subjectHuman
dc.subjectInflammation
dc.subjectLetter
dc.subjectPhenotype
dc.subjectPrevalence
dc.titleThe prevalence of asthma-COPD overlap (ACO) among COPD patients and the role of prostaglandin D2 (PGD2) in differential diagnosis “about”
dc.title.alternativeKOAH hastaları arasında astım-KOAH overlap (AKO) sıklığı ve ayırıcı tanıda prostaglandin D2 (PGD2)' nin rolü "hakkında"
dc.typeLetter

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu